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 ABSTRACT 
Statement of the Problem: Squamous cell carcinoma (SCC) is the most frequent 
oral cancer whose 5-year survival rate is 80% for early-detected lesions and nearly 
30-50% for advanced lesions. Early detection of oral cancers and precancerous le-
sions can improve the patient’s survival and decrease the morbidity. 
Purpose: This study aimed to evaluate and compare the Ki-67 and MCM3 expres-
sion in cytologic smear of oral SCC (OSCC). 
Materials and Method: We examined 48 oral brush biopsies including 28 OSCC 
and 20 healthy non-smoking samples. Immunocytochemistry staining was performed 
for Ki-67 and MCM3 by using an EnVision-labeled peroxidase system, and labeling 
index (LI) was calculated.  
Results: Out of 28 OSCC cases, 27(96.4%) cases contained MCM3 positive cells 
and 22(78%) cases contained Ki-67 positive cells. All normal mucosa were Ki-67 
and MCM3 negative. MCM3 and Ki-67 LI were significantly higher in OSCC than 
normal mucosa (p< 0.001). MCM3 LI was significantly higher than Ki-67 LI in 
OSCC group (p< 0.001). 
Conclusion: Immunocytologic evaluation of Ki-67 and MCM3 can be used for early 
detection of OSCC. Furthermore, MCM3 may be a more sensitive cytologic bi-
omarker than Ki-67 in SCC patients. 
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Introduction 
Oral cancer is a wide term that includes various forms 
of malignancy presenting in the oral cavity. [1] It is 
one of the sixth most common cancers in Asia (3% of 
malignancy) and affects nearly 300,000 patients each 
year. [2] Squamous cell carcinoma (SCC) is the most 
frequent oral cancer with different tissue presentations. 
[3] The 5-year survival rate of early-detected oral can-
cer is 80%, although for advanced lesions, this number 
decreases to nearly 30-50%. [4] Moreover, treatment 
modalities often influence the speech, nutrition, and 
swallowing. [5]  
Patients’ fear, asymptomatic primary lesions, and 
misdiagnosis result in delayed diagnosis. [6] Oral 
premalignant lesion such as leukoplakia, erythroplakia 
and oral lichen planus (OLP) may convert into oral 
cancer. [7] OLP is a chronic inflammatory disease of 
the oral mucosa, which seems to be associated with the 
process of cell-mediated immunity. [8] Prevalence of 
oral lesions is reported to be 0.5-2.2 percent. [9] The 
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risk of malignant transformation is low and the inci-
dence is nearly 0.2% per year. [3] Early detection of 
oral cancer and precancerous lesions can significantly 
improve the patient’s survival and decrease the mor-
bidity. [6] Definitive diagnosis of potentially malig-
nant and malignant lesions is through tissue biopsy and 
histopathology. However, some approaches such as 
oral brush biopsy, vital tissue staining, and light tech-
nology are suggested as diagnostic aids. Cytology was 
used to evaluate the morphology of epithelial cells, 
[10] but the primary results were not satisfactory be-
cause the cotton-tipped tool could only separate the 
surface cells. Subsequently, the brush cytology was 
introduced that can separate all the three layers of epi-
thelium, [2] and allows assessment of both morpholo-
gy and keratinization. This method is 95% accurate, 
with a painless procedure that requires no anesthesia. 
[11] Different studies have used the oral brush biopsy 
for the diagnosis of malignant lesions. [2, 12-13] The 
sensitivity of this method was reported to be in the 
range of 71% to 97.2%. [14-15] Consequently, to in-
crease the diagnostic accuracy of cytology, various 
methods were used such as bio-molecular techniques 
and determining the mutation. [16-19] Ki-67 is a pro-
tein that is detected on phases G1, S, G2, M cell cycle 
(not on G0 phase). [20] It is known as a cell prolifera-
tion factor. In premalignant lesions, expression of this 
factor was reported to increase with severity of the 
dysplasia. [9] Main chromosome maintenance (MCM) 
is another protein that plays a key role in the initiation 
and continuation of DNA replication [21] and includes 
six sub-groups (MCM 2 to MCM 7). [22] Mcm3 pro-
tein is acetylated in mammalian cells by a protein 
called MCM3AP, which was originally isolated in a 
two-hybrid screen for Mcm3 interactors. Peculiarly, 
MCM3AP inhibits DNA replication in a cell-free sys-
tem, suggesting it as a negative regulator. However, it 
clearly functions positively by promoting the nuclear 
localization and chromatin binding in MCM3. This 
paradox has yet to be resolved. MCM3AP is a splice 
variant of a much larger protein called GANP that is 
found in B cells. The association of GANP with DNA 
primase activity suggests its involvement in the regula-
tion of B-cell proliferation. [21-22]  
According to the basic role of this protein in the 
regulation of DNA replication and cell proliferation, it 
seems that the MCM is one of the important markers 
of cell cycle. [22] Some studies have also reported 
MCM3 as a diagnostic marker in human tumors. [23] 
Nonetheless, only one study has evaluated expression 
of Ki-67 markers and no study had assessed MCM3 on 
cytology samples. Therefore, the aim of this study was 
to evaluate and compare the ki-67 and MCM3 expres-
sion in cytologic smear of OSCC samples. 
 
Materials and Method 
Sampling 
By using toothbrush, oral brush biopsies were obtained 
from the patients referring to the ENT Department of 
Khalili Hospital and Oral Medicine Department of 
Shiraz Dental School from January to November 2015. 
Forty-eight oral brush biopsies were examined, includ-
ing 28 OSCC and 20 healthy, non-smoking individuals 
as control. Those suffering from any systemic disease, 
having a history of radiotherapy, chemotherapy, or 
other cancers were excluded. Each selected patient was 
asked to rinse his/her mouth with water. Having de-
termined the site of biopsy, without using local anes-
thesia, the brush was placed on the selected area and 
rotated 5-10 times with mild pressure until pinpoint 
bleeding area appeared. The cells collected with the 
brush were spread uniformly on three clean glass 
slides. They were fixed in 96% ethanol for 30 minutes, 
and then delivered to Oral Pathology Department. The 
scalpel biopsy was also done immediately in the site of 
pinpoint bleeding and the tissue was sent for patholog-
ic examination. 
Immunocytochemistry (ICC) 
ICC staining was performed by use of an EnVision-
labeled peroxidase system (Dako; Carpinteria, CA, 
USA). Antigen retrieval was performed by using Dako 
estimation and a target retrieval solution for 20 
minutes. The endogenous peroxidase was quenched by 
3% H2O2. The brush biopsies were incubated with 
both pre-diluted Ki-67 rabbit antihuman antibody and 
anti-MCM3 polyclonal antibody (Rabbit; Abcam Cor-
poration, abq7282, UK) at 1\100 dilution, each for 60 
minutes. Omission of the primary antibody was em-
ployed as a negative control; while, positive controls 
were the sections of oral squamous cell carcinoma 
which were previously found to be positive for Ki-67 
and MCM3. Brown nuclear staining was considered as  
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Figure 1a: Nuclear MCM3 expression in OSCC patients [×400],  b: Nuclear Ki-67 expression in OSCC patients [×400] 
 
positive. Samples with adequate cellularity were en-
rolled. All of the samples were examined blindly by 
two pathologists who were unaware of the clinico-
pathologic diagnosis. The positive cells were counted 
at 400x magnification and the labeling index (LI) was 
determined by assessing the percentage of positive 
stained cells out of the total epithelial cells counted. At 
least 500 cells were counted per slide. All the results 
were analyzed by using SPSS software, version 12.0 
(Statistical Package for Social Sciences; Chicago, IL, 
USA) and were subjected to exact test. Non-parametric 
Kruskal-Wallis, Mann-Whitney, Dunn test and Wil-
coxon signed-rank tests were used as appropriated. p 
Value< 0.05 was considered significant. 
 
Results 
Out of 48 samples, 25 cases were male and 23 were 
female with the mean age of 47.25 (Table 1).  
 
Table 1: Demographic data of study and control group 
 
Groups N Sex [male/female%] Mean Age 
Healthy 27.39 9/11[45-55%] 38.9 
SCC 38.35 14/14[50-50%] 55.6 
 
Table 2: The percentage of positive cases for both markers, 
as well as the mean of MCM3 and Ki-67 staining for posi-
tive cases 
 
Groups 
Type of 
marker 
Mean MCM3 and 
Ki-67 
Positive Cases 
(%) 
Healthy 
MCM3 0 0 
Ki-67 0 0 
SCC 
MCM3 0.53 [0-0.83] 96.4% 
Ki-67 0.15 [0-0.3] 78% 
 
Out of the 28 brush biopsies taken from OSCC 
cases, 27 (96.4%) contained MCM3 positive cells and 
22 (78%) contained Ki-67 positive cells (Figures 1a 
and 1b). All samples of normal mucosa were Ki-67 
and MCM3 negative. In OSCC specimen, the mean 
Ki-67 LI was 0.15 (0-0.3) and MCM3 LI was 0.53 (0-
0.8), which was significantly higher than LI of normal 
mucosa (p< 0.001). The expression of MCM3 was 
significantly higher than that of Ki-67 in OSCC group  
(p< 0.001) (Table 2). 
 
Discussion 
Various types of mucosal lesions frequently develop in 
oral cavity, a small number of which exhibit the poten-
tial to become malignant tumors. [24] Oral cancers are 
the most prevalent malignancies in the head and neck 
region, especially in developing countries where many 
individuals are affected by irritants and carcinogenic 
agents including tobacco smoke and betel nut extract. 
[25]  
Identification of small malignant or premalignant 
lesion plays an imperative role in improving the diag-
nosis and treatment of cancers. Surgical biopsy is the 
best and most accurate technique for diagnosis of oral 
cavity lesions; however, it cannot be applied for some 
patients. [24]  
Exfoliative cytology technique is a simple non-
invasive method used to investigate the mucosal sur-
face epithelial cells; it is referred to as the convention-
al cytologic smear technique. Initially, it was intro-
duced to detect the cervical cancers at early stages. 
Nonetheless, it has limited applications in oral medi-
cine [26] because contrary to the cervix uteri, the oral 
mucosa does not exhibit a transformation zone for the 
squamous and glandular epithelia to meet. Therefore, 
the atypical cells can be detectable in the deeper layer 
or at the surface of the lesions in later stages. [24] 
Consequently, the reliability of brush cytology proce-
dures should be improved by employing supportive 
techniques such as DNA cytometry, automated image 
analysis, immunocytochemistry, and molecular biolog- 
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ical tests. [19]  
Epithelial dysplasia and malignancy exhibit ec-
topic cell cycles as an important feature [27] that can 
be evaluated by proliferation markers. The present 
study focused on the proliferation of MCM3 and Ki-67 
in cytologic brush biopsies of OSCC and OLP pa-
tients. The result showed that MCM3 and Ki-67 posi-
tive epithelial cells were present in 96% and 78% of 
OSCC patients, respectively; but absent in normal mu-
cosa. So, over-expression of Ki-67 and MCM3 was 
seen in the cytology of OSCC. It indicates that some 
isolated tumor cells in brush biopsies exhibited the 
biological properties of a malignant tumor. This find-
ing emphasizes the fact that brush biopsy is a new and 
non-invasive technique for detecting oral cancers.  
Sharma et al. [28] evaluated the Ki-67 labeling 
index in OSCC patients and found that Ki-67 positive 
cells were detected in 23.3% of samples whereas in the 
current study, the Ki-67 expression was seen in 60% of 
the patients. This contrast might be due to the different 
sampling technique. Sharma et al. used wooden spatu-
la that could not accurately separate the deeper cells; 
while, our sampling with brush yielded better results. 
We noted that MCM3 expression was higher than Ki-
67 in OSCC group, which was in accordance with 
what was found by Lamerica et al. who evaluate these 
two markers in tissue specimen.  
To the best of our knowledge, there was no simi-
lar study evaluating the MCM3 in brush biopsy. Our 
result reported the MCM3 biomarker to be more sensi-
tive than Ki-67 for cytological evaluation of OSCC. 
Differences between the expression of MCM3 and Ki-
67 might be attributed to the differences in the expres-
sion of these markers in the cell cycle; i.e. MCM3 was 
expressed later in the cycle. Expression of MCM3 is 
reported in the early G1 phase and in the entire cell 
cycle; while, the expression of Ki-67 is reported in the 
late G1 to M phases. [23]  
The limitation of the present study was the con-
tamination of the specimen with blood, bacteria, ne-
crotic or proteinaceous debris that can be eliminated 
by employing liquid-based technique. 
 
Conclusion 
The present study found that Ki-67 and MCM3 im-
munocytology could be used for early detection of 
OSCC. The results also revealed that MCM3 is a more 
sensitive cytologic biomarker than Ki-67. 
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